SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001019687-10-003207
Filing Date
2010-08-27
Accepted
2010-08-27 16:26:31
Documents
5
Effectiveness Date
2010-08-27

Document Format Files

Seq Description Document Type Size
1 PEREGRINE PHARMACEUTICALS, INC. SC 14A ADDT'L MATERIALS peregrine_defa14a-043010.htm DEFA14A 30190
2 graphic1.jpg GRAPHIC 101065
3 graphic2.jpg GRAPHIC 119775
4 graphic3.jpg GRAPHIC 45471
5 graphic4.jpg GRAPHIC 42631
  Complete submission text file 0001019687-10-003207.txt   457915
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEFA14A | Act: 34 | File No.: 001-32839 | Film No.: 101044331
SIC: 2835 In Vitro & In Vivo Diagnostic Substances